Immunophenotyping by Flow Cytometry CD117 Test
Comprehensive CD117 Analysis for Advanced Cancer Detection
The Immunophenotyping by Flow Cytometry CD117 Test represents a cutting-edge diagnostic approach that utilizes sophisticated flow cytometry technology to detect and quantify CD117 (c-KIT) protein expression on cell surfaces. This advanced testing methodology provides critical insights for oncologists and hematologists in diagnosing and managing various cancer types, particularly those involving abnormal cell proliferation and differentiation.
What Does the CD117 Test Measure?
This specialized test precisely measures the presence and intensity of CD117 antigen expression on cellular surfaces. CD117, also known as c-KIT, is a tyrosine kinase receptor protein that plays a vital role in cell signaling, proliferation, and differentiation. The test detects:
- CD117 protein expression levels on hematopoietic cells
- Abnormal CD117 patterns in bone marrow and blood samples
- Specific cell populations expressing CD117 markers
- Quantitative assessment of CD117-positive cell percentages
Who Should Consider CD117 Testing?
This test is particularly recommended for patients presenting with:
- Suspected gastrointestinal stromal tumors (GIST)
- Unexplained anemia, thrombocytopenia, or leukopenia
- Abnormal blood cell counts requiring further investigation
- Suspected acute myeloid leukemia (AML)
- Mast cell disorders and systemic mastocytosis
- Germ cell tumors requiring precise characterization
- Patients with family history of hematological malignancies
Clinical Benefits of CD117 Immunophenotyping
Undergoing CD117 flow cytometry testing provides numerous clinical advantages:
- Accurate Diagnosis: Precise identification of CD117-expressing malignancies enables targeted treatment approaches
- Therapeutic Guidance: Results inform selection of tyrosine kinase inhibitor therapies
- Disease Monitoring: Track treatment response and disease progression over time
- Early Detection: Identify abnormal cell populations before clinical symptoms manifest
- Comprehensive Analysis: Multi-parameter assessment provides detailed cellular characterization
Understanding Your Test Results
Your CD117 immunophenotyping results will be carefully interpreted by our expert hematopathologists and oncologists. Normal CD117 expression patterns vary depending on the tissue type and clinical context. Abnormal results may indicate:
- Elevated CD117 expression suggesting specific cancer types
- Abnormal cell populations requiring further investigation
- Patterns consistent with hematological malignancies
- Response markers for targeted therapy monitoring
Our specialists provide comprehensive result interpretation and clinical correlation to ensure you understand the implications for your health management.
Test Pricing and Availability
| Test Description | Price |
|---|---|
| Immunophenotyping by Flow Cytometry CD117 Test – Discount Price | $88 USD |
| Immunophenotyping by Flow Cytometry CD117 Test – Regular Price | $126 USD |
Nationwide Testing Availability
GGC DNA provides comprehensive CD117 testing services across the United States with convenient locations in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, and Philadelphia. Our state-of-the-art flow cytometry laboratories ensure consistent, reliable results with rapid turnaround times.
Book Your CD117 Test Today
Take the first step toward comprehensive cancer diagnosis and management. Our specialized team is ready to assist you with scheduling, sample collection, and result interpretation. Contact us today to schedule your Immunophenotyping by Flow Cytometry CD117 Test.
Call or WhatsApp: +1(267) 388-9828
Experience the peace of mind that comes with advanced diagnostic testing from GGC DNA – your trusted partner in precision medicine and cancer diagnostics.
